LYPD3 - LY6/PLAUR domain containing 3 Gene

Homo sapiens

Also known as C4.4A

Gene ID: 27076 | Gene type: protein coding

About LYPD3

Cytogenetic location: 19q13.31 Genomic coordinates (GRCh38): 19:43,460,787-43,465,608 (from NCBI)

This gene has 4 transcripts (splice variants), 103 orthologues and 2 paralogues. Biased expression in esophagus (RPKM 319.1) and skin (RPKM 226.0).

Summary

Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

LYPD3 Products(1)

mRNA	Protein	Name
NM_014400.3	NP_055215.2	ly6/PLAUR domain-containing protein 3 precursor

LYPD3 Protein Structure

UPAR_LY6

0
100
200
300
346 a.a.

Protein Preferred Names

Protein Names

ly6/PLAUR domain-containing protein 3

2310061G07Rik

Recombinant LYPD3 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P70219	LYPD3/C4.4A Protein, Human (HEK293, His)	O95274 (L31-H286)	≥95%

Related Diseases

Diseases

Alias

Atrial Septal Defect 6

ASD6	Atrial Heart Septal Defect 6
Septal Defect, Atrial, Type 6

Mitochondrial Trifunctional Protein Deficiency

Tfp Deficiency	MTPD
Trifunctional Protein Deficiency	Trifunctional Protein Deficiency With Myopathy And Neuropathy
Tfpd	Familial Hypertrophic Cardiomyopathy
Cardiomyopathy Familial Hypertrophic	Familial Hcm
Heritable Hypertrophic Cardiomyopathy	Mtp Deficiency
Tpa Deficiency	Trifunctional Protein Deficiency, Type 2
Abetalipoproteinemia

Breast Cancer

Breast Carcinoma	Male Breast Cancer
Breast Cancer, Familial	Malignant Neoplasm Of Breast
Breast Cancer, Susceptibility To	Breast Cancer, Early-Onset
Malignant Tumor Of Breast	Carcinoma Of Male Breast
Breast Cancer, Invasive Ductal	Breast Cancer, Protection Against
Breast Cancer, Somatic	Breast Cancer, Male
Breast Cancer, Lobular, Somatic	Breast Tumor
Mammary Cancer	Mammary Tumor
Malignant Neoplasm Of Male Breast	Mammary Carcinoma
Male Breast Carcinoma	Familial Cancer Of Breast
Invasive Ductal Breast Carcinoma	Breast Cancer Susceptibility
Breast Cancer, Male, Susceptibility To	Breast Cancer, Early-Onset, Susceptibility To
Malignant Tumor Of The Breast	Mammary Neoplasm
Primary Breast Cancer	Neoplasm Of Male Breast
Carcinoma Of Breast	Breast Cancer In Men
Familial Breast Cancer	Cancer Of Breast
BC	Breast Cancer Familial
Breast Cancer Familial Male	Breast Cancer, Familial Male
Breast Male Carcinoma	Breast Neoplasms
Breast Neoplasms, Male	Mammary Tumors
Mammary Carcinomas	Cancer, Breast
Cancer, Breast, Susceptibility	Invasive Breast Ductal Carcinoma
Breast Neoplasm	Susceptibility To Breast Cancer
Mammary Neoplasms	Animal Mammary Neoplasms
Primary Malignant Neoplasm Of Breast	Infiltrating Ductal Carcinoma Of Breast
Infiltrating Duct Carcinoma Of Unspecified Site	Infiltrating Ductular Carcinoma Of Unspecified Site
Invasive Breast Carcinoma Of No Special Type	Microinvasive Carcinoma Of Breast
Carcinoma With Apocrine Differentiation

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Clinical Phase

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99718	Lupartumab		95.00%	Phase 1

Pre-clinical Phase

Bioactive Molecules (2)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-147281	BAY 1135626		96.53%	Unkown
HY-RS07917	LYPD3 Human Pre-designed siRNA Set A		/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Felis catus	LYPD3	VGNC	VGNC:63341
Bos taurus	LYPD3	VGNC	VGNC:31101
Rattus norvegicus	LYPD3	RGD	RGD:69053
Mus musculus	LYPD3	MGD	MGI:1919684
Canis familiaris	LYPD3	VGNC	VGNC:42885
Others	LYPD3	NCBI

Name
Email *

	Sorry, but the email address you supplied was invalid.